Chronic Obstructive Pulmonary Disease
Conditions
Interventions
pMDI digital intervention group:pMDI intelligent drug use sensor and digital software for COPD
pMDI control group:pMDI intelligent drug use sensor
DPI/SMI digital intervention group:digital software for COPD
DPI/SMI control group:No intervention
Sponsors
Tianjin Chest Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Subjects who met all the following criteria were included in this study. (1) fully understand and sign the written informed consent. (2) patients with chronic obstructive pulmonary disease who meet the diagnostic criteria of the guidelines for the diagnosis and treatment of chronic obstructive Pulmonary Disease (2021 revised Edition). (3) permanent residents whose patients were = 18 years old when they were enrolled in the group. (4) the patients were in stable phase of COPD at the time of entering the group, and were given inhaled drug maintenance therapy.
Exclusion criteria
Exclusion criteria: Subjects will not be included in this study if they meet any of the following criteria. (1) Women during pregnancy or lactation. (2) there is cognitive disorder, which the researchers believe will affect the completion of the study. (3) there were rapidly progressive or unstable cardiovascular diseases, active pulmonary tuberculosis, neuromuscular diseases, immune system diseases and hematological diseases. (4) A history of allergy or intolerance to any component of sensor Acrylonitrile Butadiene Styrene resin material (similar to TV shell material).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compliance with inhalation medication; | — |
Secondary
| Measure | Time frame |
|---|---|
| Acute exacerbation of COPD; | — |
Countries
China
Contacts
Public ContactXiaoyun Zhao
Tianjin Chest Hospital
Outcome results
None listed